Partner Headlines - CLVS

  1. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO ...

    TalkMarkets
  2. Poor Stock Action & Trading

    TalkMarkets
  3. 6 Best Performing Drug Stocks Of September 2016

    TalkMarkets
  4. 5 Top Performing Stocks Of The Best ETF Of Q3

    TalkMarkets
  5. Gilead Slips As Former Bull Turns Bearish On Hep C Business

    TalkMarkets
  6. Benzinga's Top Initiations

    Benzinga
  7. Clovis Oncology Receives Notification of PDUFA Extension for ...

    Benzinga
  8. Benzinga's M&A Chatter for Tuesday December 1, 2015

    Benzinga
  9. Kyle Bass Builds Bull Case for Clovis Oncology

    GuruFocus
  10. Clovis Oncology Continues Lower After Consolidation

    Benzinga
  11. KaloBios, Valeant Lead Week's 5 Top Drug Stock Gainers

    IBD
  12. Morning Market Losers

    Benzinga
  13. Benzinga's Top Downgrades

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. Biotech Clovis Oncology

    IBD
  16. Mid-Afternoon Market Update: Dow Surges More Than 200 Points; ...

    Benzinga
  17. Mid-Day Market Update: Starwood Drops Following Announcement ...

    Benzinga
  18. Clovis Stumbles, AstraZeneca Leads Cancer Drug Race

    IBD
  19. What The FDA Gave Clovis Oncology In June 2013, It Has Taken ...

    Benzinga
  20. Mid-Morning Market Update: Markets Edge Higher; Marriott To Acquire ...

    Benzinga
  21. Morning Market Losers

    Benzinga
  22. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  23. Clovis Oncology Announces U.S. and E.U. Regulatory Milestones ...

    Benzinga
  24. Clovis Oncology Announces Data Presentations at 16th World Conference ...

    Benzinga
  25. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib ...

    Benzinga
  26. Benzinga's Top Upgrades

    Benzinga
  27. Clovis Oncology Announces Exercise in Full of Underwriters' Option ...

    Benzinga
  28. Clovis Oncology Initiates Rolling NDA Submission to the FDA for ...

    Benzinga
  29. Morning Market Losers

    Benzinga
  30. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus
  31. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD
  32. Benzinga's Volume Movers

    Benzinga
  33. Morning Market Gainers

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga
  37. Earnings Scheduled For February 25, 2015

    Benzinga
  38. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  39. Morning Market Losers

    Benzinga
  40. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration ...

    Benzinga
  41. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  44. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  45. Market Wrap For June 5: Markets Positive Before Friday's Employment ...

    Benzinga
  46. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  47. Market Wrap For June 4: Markets Slightly Higher On Light Volume, ...

    Benzinga
  48. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  49. Benzinga's Volume Movers

    Benzinga
  50. Benzinga's Top #PreMarket Gainers

    Benzinga
  51. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive ...

    Benzinga
  52. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  53. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  54. Benzinga's Top Initiations

    Benzinga
  55. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam ...

    Benzinga
  56. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers ...

    Benzinga
  57. Benzinga's Top #PreMarket Gainers

    Benzinga
  58. Clovis Oncology Announces 2014 Objectives, Financial Guidance ...

    Benzinga
  59. What The Top Stocks Of 2013 Had In Common

    IBD
  60. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation ...

    Benzinga
  61. Clovis Oncology Announces 2M Share Offering by Selling Stockholders ...

    Benzinga
  62. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  63. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  64. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects ...

    Benzinga
  65. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats ...

    Benzinga
  66. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity ...

    Benzinga
  67. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  68. QIAGEN Announces Partnership With Clovis Oncology to Co-develop ...

    Benzinga
  69. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  70. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  71. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares ...

    Benzinga
  72. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit ...

    Benzinga
  73. Morning Market Losers

    Benzinga
  74. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  75. Benzinga's Top Initiations

    Benzinga
  76. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  77. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting ...

    Benzinga
  78. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  79. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga
  80. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies ...

    Benzinga
  81. Benzinga's Top Pre-Market Losers

    Benzinga
  82. Health Care Sector Wrap

    FoxBusiness
  83. Health Care Sector Wrap

    FoxBusiness
  84. Clovis Oncology and Array BioPharma Announce Agreement to Discover ...

    Benzinga
  85. Clovis Oncology Announces FDA Acceptance of Investigational New ...

    Benzinga
  86. End-of-Day Market Summary for January 18, 2012

    Benzinga
  87. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  88. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  89. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center